Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomesJohn A. Glaspy, Heinz Ludwig|British Journal of Cancer|2010Cited by 234
Dietary Modulation of Omega-3/Omega-6 Polyunsaturated Fatty Acid Ratios in Patients With Breast CancerDilprit Bagga, John A. Glaspy, Hu Wang et al.|JNCI Journal of the National Cancer Institute|1997Cited by 91
Incidence of Tumor-Cell Contamination in Leukapheresis Products of Breast Cancer Patients Mobilized With Stem Cell Factor and Granulocyte Colony-Stimulating Factor (G-CSF) or With G-CSF AloneWilbur A. Franklin, Elizabeth J. Shpall, John A. Glaspy et al.|Blood|1999Cited by 57
Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.John A. Glaspy, Barbara Finck, Paula G. O’Connor et al.|Journal of Clinical Oncology|2017Cited by 8